Steve Seedhouse
Stock Analyst at Cantor Fitzgerald
(0.96)
# 3,765
Out of 4,944 analysts
4
Total ratings
25%
Success rate
-0.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Steve Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals | Maintains: Overweight | $39 → $40 | $23.90 | +67.36% | 1 | Aug 1, 2025 | |
| INVA Innoviva | Initiates: Overweight | $26 | $20.09 | +29.42% | 1 | Jul 11, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $52 | $24.56 | +111.73% | 1 | Jul 11, 2025 | |
| HROW Harrow | Initiates: Overweight | $76 | $34.83 | +118.20% | 1 | Jul 11, 2025 |
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Overweight
Price Target: $39 → $40
Current: $23.90
Upside: +67.36%
Innoviva
Jul 11, 2025
Initiates: Overweight
Price Target: $26
Current: $20.09
Upside: +29.42%
Tvardi Therapeutics
Jul 11, 2025
Initiates: Overweight
Price Target: $52
Current: $24.56
Upside: +111.73%
Harrow
Jul 11, 2025
Initiates: Overweight
Price Target: $76
Current: $34.83
Upside: +118.20%